Medical Doctor Program year 2022 Reported 2019–2022 Source: CMS Open Payments, 2026 publication

Neal Rothschild

Medical Oncology West Palm Beach, FL Medical Doctor

NPI 1568468544 CMS profile 252878

1309 N Flagler Dr, Mailstop 4017, West Palm Beach, FL 33401

Open in the dashboard

General payments

$3,994

259 records reported · program years 2019–2022

Research payments

$0

Paid to them · None reported · program years 2019–2022

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$466,593 paid to institutions, not to them · program years 2019–2025

Through program year 2022, Neal Rothschild of West Palm Beach, FL is reported in the CMS Open Payments database as having received $3,994 across 259 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $466,593 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 48th percentile of Medical Oncology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2022 General $484 29
2021 General $1,820 116
2020 General $760 49
2019 General $930 65

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Neal Rothschild
  • Medical Oncology median
  • Middle half of Medical Oncology
  • National median

In program year 2025, general payments to Neal Rothschild were reported at $0. Among 3,316 Medical Oncology profiles paid that year, the median was $1,128 and the middle half received between $147 and $5,675.

Show as a table
Year Neal Rothschild Medical Oncology median Middle half National median
2019 $930 $968 $140–$6,658 $163
2020 $760 $747 $102–$5,891 $114
2021 $1,820 $430 $50–$4,098 $132
2022 $484 $812 $127–$4,907 $149
2023 $0 $957 $144–$5,248 $160
2024 $0 $1,042 $149–$5,650 $164
2025 $0 $1,128 $147–$5,675 $169

Breakdown

Who paid General payments · program years 2019–2022
  1. E.R. Squibb & Sons, L.L.C. $304 22 payments
  2. Eisai Inc. $263 15 payments
  3. Seattle Genetics, Inc. $239 16 payments
  4. Genzyme Corporation $236 16 payments
  5. AstraZeneca Pharmaceuticals LP $235 15 payments
  6. Pfizer Inc. $213 14 payments
  7. Pharmacyclics LLC, An AbbVie Company $198 15 payments
  8. Celgene Corporation $192 12 payments
  9. Janssen Biotech, Inc. $149 10 payments
  10. Aurobindo Pharma USA, Inc. $147 10 payments
  11. Other $1,818 114 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2022
  1. Food and Beverage $3,994 259 payments
Products named General payments · program years 2019–2022
  1. Lenvima $223 12 payments
  2. OPDIVO $219 16 payments
  3. ADCETRIS $175 11 payments
  4. IMBRUVICA Oncology $171 13 payments
  5. REBLOZYL $157 9 payments
  6. LIBTAYO $134 8 payments
  7. IMBRUVICA Oncology $117 7 payments
  8. SARCLISA $106 7 payments
  9. ELITEK $106 7 payments
  10. CYRAMZA $100 7 payments
  11. Other $3,478 226 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

259 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Medical Oncology in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2022

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record